OLANZAPINE CH olanzapine 2.5 mg tablets bottle

País: Austràlia

Idioma: anglès

Font: Department of Health (Therapeutic Goods Administration)

ingredients actius:

olanzapine, Quantity: 2.5 mg

Disponible des:

Amneal Pharma Australia Pty Ltd

Designació comuna internacional (DCI):

Olanzapine

formulario farmacéutico:

Tablet, uncoated

Composición:

Excipient Ingredients: lactose monohydrate; magnesium stearate; crospovidone; hyprolose

Vía de administración:

Oral

Unidades en paquete:

30

tipo de receta:

(S4) Prescription Only Medicine

indicaciones terapéuticas:

Olanzapine is indicated for the treatment of schizophrenia and related psychoses. ,Olanzapine alone or in combination with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder. ,Olanzapine is indicated for preventing recurrence of manic, mixed or depressive episodes in Bipolar I Disorder.

Resumen del producto:

Visual Identification: Yellow coloured, circular, biconvex uncoated tablets, debossed with "C" on one side and "45" on the other side; Container Type: Bottle; Container Material: HDPE; Container Life Time: 18 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Estat d'Autorització:

Licence status A

Data d'autorització:

2011-11-15